TITLE

Managing psoriasis in pediatric cases

AUTHOR(S)
Petrou, Ilya
PUB. DATE
April 2006
SOURCE
Dermatology Times;Apr2006, Vol. 27 Issue 4, p38
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses several options for treating psoriasis in children. Methotrexate can reduce the incidence of vascular incidence in patients with psoriasis. However, methotrexate increases homocysteine levels, which are already elevated in patients with psoriasis. Elidel cream and Protopic are also used to treat inverse psoriasis in children. Corticosteroids remain a mainstay treatment for psoriasis.
ACCESSION #
20499019

 

Related Articles

  • tazarotene.  // Royal Society of Medicine: Medicines;2002, p523 

    The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands...

  • Treating Itch in Psoriasis. Dawn, Aerlyn; Yosipovitch, Gil // Dermatology Nursing;Jun2006, Vol. 18 Issue 3, p227 

    The article presents a study on the effective management and treatment of psoriatic itch. Patients with chronic pruritus often have difficulty sleeping, problems concentrating, lowered sex drive, and depression. The treatments recommended for psoriatic itch are tar products, topical...

  • A once-daily psoriasis ointment.  // Cortlandt Forum;May2006, Vol. 19 Issue 5, p19 

    This article presents information about the Taclonex ointment from Warner Chilcott PLC. Calcipotriene hydrate and betamethasone dipropionate are the active ingredients of this ointment. The ointment is used for treating psoriasis vulgaris. Calcipotriene is metabolized in the liver to less potent...

  • New oral psoriasis agents show promise. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS13 

    Introduces different oral treatment for psoriasis. Side effects of the retinoid, an oral tazarotene; Acquisition of a new oral formulation of the drug BG-12 oral fumarate by Biogen; Discussion on the effects of oral pimecrolimus on psoriatic patients.

  • Biologies for psoriasis pulling their weight. Wilson, Fred // Dermatology Times;Sep2004 Supplement, Vol. 25, pS18 

    The article discusses the effect of biologic therapy on psoriatic patients. Consideration of Amevive as the first biologic drug approved for moderate to severe plaque psoriasis; Elaboration on the effects of the drug, Raptiva; Responses of patients to Remicade infusions.

  • Physician says TNF-a antagonists very safe, overall. Guttman, Cheryl // Dermatology Times;Sep2004 Supplement, Vol. 25, pS33 

    Reports that TNF-a antagonists are safe for psoriatic patients. Presentation of several antagonists safe for psoriatic therapy; Discussion on the risks of serious infections and malignancies related to the immunosuppressive activity of the TNF-a antagonist; Effects on patients after treated with...

  • Study shows leading drugs' effectiveness against psoriasis. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS34 

    The article discusses the effectiveness of leading drugs against psoriasis. Statement of Craig L. Leonardi, associate dermatologist of St. Louis University in Missouri, on the effectiveness of Biogen's alefacept; Clarifications on the length of effectiveness of some drugs; Discussion on the...

  • new drugs for psoriasis might be lifesavers. Steinmehl, Eric; Martin, Adam // Health (Time Inc. Health);Mar2004, Vol. 18 Issue 2, p68 

    Provides information on biologics, a drug for treating psoriasis. Annual cost of the treatment; Percentage of people with psoriasis who consider committing suicide; Description of psoriasis.

  • Patient Profiles in Psoriatic Disease: A Case-Based Approach.  // Dermatology Nursing;Oct2007 Supplement, Vol. 19, p5 

    The article cites a study that describes the basic characteristics of psoriatic disease, a dermatologic disorder that affects residents in the U.S. It discusses the need for appropriate management for early and aggressive intervention of this condition. It highlights the principles that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics